Bianchini, Giampaolo

Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease

Bianchini, G., Balko, J. M., Mayer, I. A., Sanders, M. E., & Gianni, L. (2016) · Nature Reviews Clinical Oncology

Breast Cancer Treatment StudiesBRCA gene mutations in cancer

Cited by 3,079

Recombinant human erythropoietin antagonizes trastuzumab treatment of breast cancer cells via Jak2-mediated Src activation and PTEN inactivation

Liang, K., Esteva, F. J., Albarracin, C., Stemke-Hale, K., Lu, Y., Bianchini, G., Yang, C.-Y., Li, Y., Li, X., Chen, C.-T., et al. (2010) · Cancer Cell

HER2/EGFR in Cancer ResearchErythropoietin and Anemia Treatment

Cited by 139

Distinct p53 gene signatures are needed to predict prognosis and response to chemotherapy in ER-positive and ER-negative breast cancers

Coutant, C., Rouzier, R., Qi, Y., Lehmann-Che, J., Bianchini, G., Iwamoto, T., Hortobagyi, G. N., Symmans, W. F., Uzan, S., Andre, F., et al. (2011) · Clinical Cancer Research

Breast Cancer Treatment StudiesCancer-related Molecular Pathways

Cited by 64

Association between red and processed meat consumption and colorectal cancer risk: a comprehensive meta-analysis of prospective studies

Ungvari, Z., Fekete, M., Varga, P., Lehoczki, A., Munkácsy, G., Fekete, J. T., Bianchini, G., Ocana, A., Buda, A., Ungvari, A., et al. (2025) · GeroScience

Nutritional Studies and DietColorectal Cancer Screening and Detection

Cited by 56

Personalized Risk-Benefit Ratio Adaptation of Breast Cancer Care at the Epicenter of COVID-19 Outbreak.

Viale, G., Licata, L., Sica, L., Zambelli, S., Zucchinelli, P., Rognone, A., Aldrighetti, D., Di Micco, R., Zuber, V., Pasetti, M., et al. (2020) · The Oncologist

COVID-19 and healthcare impactsCOVID-19 Impact on Reproduction

Cited by 35

Surrogate markers for targeted therapy-based treatment activity and efficacy

Bianchini, G., & Gianni, L. (2011) · JNCI Monographs

Breast Cancer Treatment StudiesGastric Cancer Management and Outcomes

Cited by 2